Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.

Kanellopoulos A, Koster L, de Lavallade H, Ortí G, Francis S, Passweg J, Apperley J, Bethge W, Rabitsch W, Clay J, Forcade E, Hurst E, Besley C, Kinsella F, Aljurf M, Huang H, Ho A, Hilgendorf I, Choi G, Ayuk F, Grzegorz H, Stelljes M, Richardson D, Morozova E, Prejzner W, Zeiser R, Armstrong C, Raj K, Drozd-Sokolowska J, Chalandon Y, McLornan DP

Open source

DOI
10.1038/s41409-026-02862-9
Published
2026 Jun
Container
Bone marrow transplantation
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41409-026-02862-9,
  title = {Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.},
  author = {Kanellopoulos A and Koster L and de Lavallade H and Ortí G and Francis S and Passweg J and Apperley J and Bethge W and Rabitsch W and Clay J and Forcade E and Hurst E and Besley C and Kinsella F and Aljurf M and Huang H and Ho A and Hilgendorf I and Choi G and Ayuk F and Grzegorz H and Stelljes M and Richardson D and Morozova E and Prejzner W and Zeiser R and Armstrong C and Raj K and Drozd-Sokolowska J and Chalandon Y and McLornan DP},
  year = {2026},
  journal = {Bone marrow transplantation},
  doi = {10.1038/s41409-026-02862-9},
  url = {https://doi.org/10.1038/s41409-026-02862-9}
}

RIS

TY  - JOUR
TI  - Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.
AU  - Kanellopoulos A
AU  - Koster L
AU  - de Lavallade H
AU  - Ortí G
AU  - Francis S
AU  - Passweg J
AU  - Apperley J
AU  - Bethge W
AU  - Rabitsch W
AU  - Clay J
AU  - Forcade E
AU  - Hurst E
AU  - Besley C
AU  - Kinsella F
AU  - Aljurf M
AU  - Huang H
AU  - Ho A
AU  - Hilgendorf I
AU  - Choi G
AU  - Ayuk F
AU  - Grzegorz H
AU  - Stelljes M
AU  - Richardson D
AU  - Morozova E
AU  - Prejzner W
AU  - Zeiser R
AU  - Armstrong C
AU  - Raj K
AU  - Drozd-Sokolowska J
AU  - Chalandon Y
AU  - McLornan DP
PY  - 2026
JO  - Bone marrow transplantation
DO  - 10.1038/s41409-026-02862-9
UR  - https://doi.org/10.1038/s41409-026-02862-9
ER  - 

APA

A, K., L, K., H, D. L., G, O., S, F., J, P., J, A., W, B., W, R., J, C., E, F., E, H., C, B., F, K., M, A., H, H., A, H., I, H., G, C., F, A., H, G., M, S., D, R., E, M., W, P., R, Z., C, A., K, R., J, D., Y, C., & DP, M. (2026). Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.. Bone marrow transplantation. https://doi.org/10.1038/s41409-026-02862-9

Source records